Welcome to Altravax

Altravax is a biopharmaceutical company focused on the discovery and development of new vaccines and the improvement of existing vaccines to fight infectious diseases. Our vaccines are designed to elicit strong and appropriate immune responses that can prevent infections or treat existing ones. [Read more...]

Pipeline

Our product pipeline includes a tetravalent dengue vaccine, a vaccine for Hepatitis B and improved preventative vaccines for influenza and HIV-1.

View our Product Pipeline

Platform

Altravax is currently funded by the Department of Defense to apply our vaccine screening platform to several infectious disease targets.

View our Platform